Ruth Freeman
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Biochemistry top 5%
- Antioxidant Activity and Oxidative Stress
Papers in
-
- Mitochondrial Function and Pathology 3
- Coenzyme Q10 studies and effects 2
- Angiogenesis and VEGF in Cancer 2
- Cell death mechanisms and regulation 2
-
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Stephen J. Ralph (5 shared papers)Jiřı́ Neužil (5 shared papers)Lubomír Procházka (4 shared papers)Immo E. Scheffler (3 shared papers)Jeffrey C. Dyason (3 shared papers)Lan‐Feng Dong (4 shared papers)Karel Vališ (3 shared papers)Jaroslav Tuřánek (3 shared papers)
- Journals
- Journal of Bioenergetics and Biomembranes (1 paper)Clinical Cancer Research (1 paper)Blood Cells Molecules and Diseases (1 paper)Oncotarget (1 paper)Experimental Hematology and Oncology (1 paper)
- Partner nations
- AustraliaUnited StatesCzechia
In The Last Decade
Ruth Freeman
10 papers receiving 817 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 300
- Biochemistry 103
- Molecular Biology 502
- Biomaterials 86
- Toxicology 18
Countries citing papers authored by Ruth Freeman
This map shows the geographic impact of Ruth Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Freeman more than expected).
Fields of papers citing papers by Ruth Freeman
This network shows the impact of papers produced by Ruth Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Freeman. The network helps show where Ruth Freeman may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruth Freeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 251 | |
| 2 | 2007 | 110 | |
| 3 | 2009 | 105 | |
| 4 | 2012 | 104 | |
| 5 | 2007 | 88 | |
| 6 | 2010 | 45 | |
| 7 | Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by c-MYB. | 2000 | 41 |
| 8 | 2013 | 36 | |
| 9 | 2016 | 30 | |
| 10 | 2001 | 16 |
About Ruth Freeman
Ruth Freeman is a scholar working on Molecular Biology, Cancer Research, Biochemistry, Pharmacology and Genetics, having authored 10 papers that have together received 826 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (3 papers), Antioxidant Activity and Oxidative Stress (2 papers), Coenzyme Q10 studies and effects (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Cell death mechanisms and regulation (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Estrogen and related hormone effects (1 paper) and Hemoglobinopathies and Related Disorders (1 paper). The work is most often cited by research in Cancer Research (300 citations), Biochemistry (103 citations), Molecular Biology (502 citations), Biomaterials (86 citations) and Toxicology (18 citations). Ruth Freeman has collaborated with scholars based in Australia, United States and Czechia. Frequent co-authors include Stephen J. Ralph, Jiřı́ Neužil, Lubomír Procházka, Immo E. Scheffler, Jeffrey C. Dyason, Lan‐Feng Dong, Karel Vališ, Jaroslav Tuřánek, Renata Zobalová and Paul K. Witting. Their work appears in journals such as Journal of Bioenergetics and Biomembranes, Clinical Cancer Research, Blood Cells Molecules and Diseases, Oncotarget and Experimental Hematology and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.